Cosmos Health Inc. (“Cosmos Health” or “the Company”) (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, according to a preliminary list of additions posted May 19.
Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
Greg Siokas, Chief Executive Officer of Cosmos Health, stated: “We are thrilled to announce that Cosmos Health is set to join the prestigious Russell Microcap® Index, an important performance benchmark of the stock market. This is a significant recognition of how far Cosmos has come in such a short period of time. We started our journey on NASDAQ last year and since then have evolved tremendously, turning Cosmos into a diversified healthcare group with a strong balance sheet and significant growth prospects in the pipeline.
Joining the Russell Microcap® Index is a significant milestone for Cosmos Health. Our inclusion is a result of our consistent performance, robust market capitalization, and adherence to FTSE Russell’s strict membership criteria. It reflects the market’s recognition of our strong presence in the global healthcare industry, enhancing our liquidity as well as our visibility and credibility with the investment community.
We are truly grateful to our shareholders for their unwavering trust and support throughout this journey. Their confidence in Cosmos Health has been pivotal in this success, and we remain dedicated to delivering sustainable growth and generating value for them. Stay tuned as the best is yet to come!”
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $12.1 trillion in assets are benchmarked against Russell’s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.
For more information on the Russell Microcap® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
